Nevro (NVRO) came out with a quarterly loss ... A quarter ago, it was expected that this maker of an electrical implant that treats leg and back pain would post a loss of $0.82 per share when ...

Nevro (NVRO) could be a solid choice for investors ... This maker of an electrical implant that treats leg and back pain is expected to earn -$2.40 per share for the fiscal year ending December ...

(AP) — Nevro Corp. (NVRO) on Tuesday reported a loss ... The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also topped ...

enabling technologies and future implant solutions. Furthermore, the company’s scale and operational discipline will help optimize Nevro’s financial performance, driving enhanced profitability ...

StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

Total U.S. permanent implant procedures declined 7% year over year, while U.S. trial procedures decreased 14.2% year over year. During the fourth quarter of 2024, Nevro made significant ...

U.S. permanent implant procedures decreased by 7.0% compared ... an increase of $15.5 million from September 30, 2024. Nevro's full-year 2024 worldwide revenue was $408.5 million, a decrease ...